Literature DB >> 11785064

Pathophysiology of essential hypertension: role of the pump, the vessel, and the kidney.

Ashley E Cain1, Raouf A Khalil.   

Abstract

Essential hypertension is characterized by significant and persistent elevations in arterial pressure. Hypertension is a multifactorial disorder that may involve abnormalities in the functions of the heart pump, the blood vessels, and the kidneys. Short-term and long-term regulation of arterial pressure is influenced by changes in cardiac function, the peripheral vascular resistance, and the renal control mechanisms of plasma electrolytes and volume. Increases in the heart rate and stroke volume lead to increases in the cardiac output and could contribute to increases in arterial pressure particularly in relatively young individuals. Vascular endothelial cell dysfunction could lead to reduction in endothelium-derived relaxing factors such as nitric oxide, prostacyclin, and endothelium-derived hyperpolarizing factor, or increased production of contracting factors such as endothelin-1 and thromboxane A2. Also, increased activity of signaling pathways of vascular smooth muscle contraction such as [Ca(2+)]i, protein kinase C, mitogen-activated protein kinase, and Rho kinase could enhance vasoconstriction. The decreased vascular relaxation and excessive vasoconstriction lead to significant increases in the peripheral vascular resistance and arterial pressure over time, particularly with aging. Alterations in body fluid regulation by the kidneys could lead to salt and water retention, increased plasma volume, and cardiac output. Also, activation of the renin-angiotensin system increases the levels of angiotensin II in the plasma, leading to generalized vasoconstriction, or locally in the kidneys, leading to salt and water retention. Individual changes in cardiac, vascular, or renal function seldom occur separately, and, if so, they may lead to mild or moderate increases in arterial pressure. Combined alterations in cardiac, vascular, and renal functions are more common and are often associated with pathologic increases in arterial pressure and established hypertension. Copyright 2002 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2002        PMID: 11785064

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  21 in total

Review 1.  Ca2+, calmodulin, and cyclins in vascular smooth muscle cell cycle.

Authors:  Vera V Koledova; Raouf A Khalil
Journal:  Circ Res       Date:  2006-05-26       Impact factor: 17.367

2.  Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.

Authors:  Luminita H Pojoga; Tham M Yao; Lauren A Opsasnick; Waleed T Siddiqui; Ossama M Reslan; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-07-16       Impact factor: 4.030

3.  Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension.

Authors:  Luminita H Pojoga; Jonathan S Williams; Tham M Yao; Abhinav Kumar; Joseph D Raffetto; Graciliano R A do Nascimento; Ossama M Reslan; Gail K Adler; Gordon H Williams; Yujiang Shi; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-26       Impact factor: 4.733

4.  CYBA (p22phox) variants associate with blood pressure and oxidative stress markers in hypertension: a replication study in populations of diverse altitudes.

Authors:  Rahul Kumar; Samantha Kohli; Zahara Ali; Kanika Duhan; Rekhbala Ram; Mohit Gupta; Sanjay Tyagi; Ghulam Mohammad; Ma Qadar Pasha
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

Review 5.  Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension.

Authors:  Daisy A Salamanca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2005-09-01       Impact factor: 5.858

Review 6.  The role of angiotensin II in regulating vascular structural and functional changes in hypertension.

Authors:  Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

7.  Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation.

Authors:  Jin Hee Lee; Thomas Palaia; Louis Ragolia
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-03       Impact factor: 4.249

8.  Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension.

Authors:  José M Fernández-Fernández; Marta Tomás; Esther Vázquez; Patricio Orio; Ramón Latorre; Mariano Sentí; Jaume Marrugat; Miguel A Valverde
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 9.  Cellular mediators of renal vascular dysfunction in hypertension.

Authors:  Bharathy Ponnuchamy; Raouf A Khalil
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

10.  Upregulation of Na+ and Ca2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats.

Authors:  Maria V Pulina; Alessandra Zulian; Roberto Berra-Romani; Olga Beskina; Amparo Mazzocco-Spezzia; Sergey G Baryshnikov; Italia Papparella; John M Hamlyn; Mordecai P Blaustein; Vera A Golovina
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.